IP Library Granted Patent US 7,544,364
Granted Patent B2
US 7,544,364 · App. 11/410,597 · Granted Jun 9, 2009

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,364
App. No.
11/410,597
Granted
Jun 9, 2009
Kind
B2
Abstract

Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Claims (9)

1. A pharmaceutical composition comprising:

(a) a cyclodextrin; and (b) a glycopeptide antibiotic or a pharmaceutically acceptable salt thereof; wherein the glycopeptide antibiotic has the formula:

Wherein R 20 is a lipid substituent containing from 10 to 40 carbon atoms, and optionally containing heteroatoms selected from halo, oxygen, nitrogen, sulfur and phosphorous; and wherein R 19 is hydrogen, and R 5 is a substituent of the formula: —CH 2 —NH—R a —P(O)(OH) 2 wherein R a is alkylene.

2. The pharmaceutical composition of claim 1 , wherein the cyclodextrin is hydroxypropyl-β-cyclodextrin.

3. The pharmaceutical composition of claim 1 , wherein the cyclodextrin is sulfobutyl ether β-cyclodextrin.

4. The pharmaceutical composition of claim 1 , wherein the composition is a lyophilized powder.

5. The pharmaceutical composition of claim 1 , wherein the cyclodextrin comprises about 1 to 40 weight percent of the composition.

6. The pharmaceutical composition of claim 1 , wherein the glycopeptide antibiotic is in the form of a pharmaceutically acceptable salt.

7. The pharmaceutical composition of claim 1 , wherein the glycopeptide antibiotic is in the form of a hydrochloride salt.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: JUDICE, J. KEVIN
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: JUDICE, J. KEVIN; SHAW, JENG-PYNG; MU, YONGQI; CONNER, MICHAEL W.
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: PACE, JOHN L.
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0493 →
MERGER Recorded Oct 13, 2009
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 023364/0442 →